<DOC>
	<DOCNO>NCT01224899</DOCNO>
	<brief_summary>The investigator seek evaluate feasibility safety surgical sympathetic blockade systolic heart failure patient secondary assess cardiovascular consequence .</brief_summary>
	<brief_title>Surgical Sympathetic Blockade Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Heart Failure , Systolic</mesh_term>
	<criteria>chronic heart failure ( least 1 month symptom onset ) NYHA functional class II III LV ejection fraction 40 % low rest heart rate high 65 bpm either maximum betablocker therapy accord guideline betablocker use intolerance . NYHA functional class I IV cardiogenic shock rest heart rate â‰¤ 65 bpm systolic blood pressure &lt; 90 mmHg sustain ventricular tachycardia eligibility surgical procedure procedurelimiting comorbidity presence ICD pacemaker valvar , chagasic congenital cardiomyopathy age &gt; 70 year patient refusal contraindication videothoracoscopy decompensated thyroid disease atrial fibrillation flutter active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Sympathetic Nervous System</keyword>
	<keyword>Sympathectomy</keyword>
	<keyword>Adrenergic beta-Antagonists</keyword>
	<keyword>Ventricular Dysfunction , Left</keyword>
</DOC>